You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

Article info

Article menu
Download PDFPDF
Original Articles
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

Authors

  1. Address correspondence and reprint requests to: Anjila Koul, MD, PhD, Departments of Oncology, Lund University Hospital, SE-221 85, Lund Sweden. Email: anjila.koul{at}onk.lu.se.

Citation

KOUL A, BENDAHL P, BORG Å, et al
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
International Journal of Gynecologic Cancer 2002;12:362-371.

Publication history

  • First published July 1, 2002.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2002 IGCS